NanoViricides, Inc.
NNVC · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.39 | 0.00 | 0.07 |
| FCF Yield | -6,870,078.76% | -7.41% | -10.62% | -10.51% |
| EV / EBITDA | 0.63 | -11.03 | -8.00 | -9.22 |
| Quality | ||||
| ROIC | -25.04% | -28.14% | -25.46% | -19.82% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.89 | 0.81 | 0.90 | 1.08 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -98,017,896.55% | 14.01% | 9.13% | 17.06% |
| Safety | ||||
| Net Debt / EBITDA | 0.63 | 0.80 | 1.26 | 2.16 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -13,819.13 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -715.28 | 0.00 | 0.00 |